A detailed history of Tower Research Capital LLC (Trc) transactions in Pulmonx Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,861 shares of LUNG stock, worth $36,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,861
Previous 7,552 22.39%
Holding current value
$36,689
Previous $47,000 2.13%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.59 - $8.58 $9,452 - $14,508
-1,691 Reduced 22.39%
5,861 $48,000
Q2 2024

Aug 13, 2024

BUY
$5.77 - $9.82 $39,720 - $67,600
6,884 Added 1030.54%
7,552 $47,000
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $89,207 - $150,045
-10,242 Reduced 93.88%
668 $6,000
Q4 2023

Feb 13, 2024

SELL
$7.89 - $13.14 $6,674 - $11,116
-846 Reduced 7.2%
10,910 $139,000
Q3 2023

Nov 14, 2023

BUY
$9.88 - $14.0 $106,407 - $150,780
10,770 Added 1092.29%
11,756 $121,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $873 - $1,105
-81 Reduced 7.59%
986 $12,000
Q1 2023

May 09, 2023

SELL
$7.49 - $12.54 $143,358 - $240,015
-19,140 Reduced 94.72%
1,067 $12,000
Q4 2022

Feb 10, 2023

BUY
$4.92 - $17.35 $88,210 - $311,068
17,929 Added 787.05%
20,207 $170,000
Q3 2022

Nov 10, 2022

SELL
$15.35 - $23.99 $45,650 - $71,346
-2,974 Reduced 56.63%
2,278 $38,000
Q2 2022

Aug 15, 2022

SELL
$14.0 - $27.95 $64,946 - $129,660
-4,639 Reduced 46.9%
5,252 $77,000
Q1 2022

May 12, 2022

BUY
$21.13 - $35.65 $162,172 - $273,613
7,675 Added 346.34%
9,891 $245,000
Q4 2021

Feb 14, 2022

BUY
$29.72 - $45.1 $38,487 - $58,404
1,295 Added 140.61%
2,216 $71,000
Q3 2021

Nov 15, 2021

SELL
$35.98 - $44.48 $149,460 - $184,769
-4,154 Reduced 81.85%
921 $34,000
Q2 2021

Aug 16, 2021

BUY
$37.61 - $48.0 $106,812 - $136,320
2,840 Added 127.07%
5,075 $224,000
Q1 2021

May 17, 2021

BUY
$44.0 - $67.54 $87,736 - $134,674
1,994 Added 827.39%
2,235 $102,000
Q4 2020

Feb 16, 2021

BUY
$39.31 - $69.02 $9,473 - $16,633
241 New
241 $17,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $233M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.